Tag: Infliximab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Infliximab

Link Between Antidrug Antibodies and bDMARDs Nonresponse in Patients With RA

Added to Collection on: 2023-09-11 16:50:47

Tags for this article:

Monoclonal antibodies
Immunosuppressants
Immunology
Disease-modifying antirheumatic drugs
Biotechnology
Rheumatoid arthritis
TNF inhibitor
Infliximab
Rituximab
Etanercept
Tocilizumab
Rheumatology

Click the tags to see associated articles and topics

View Article Details
TNF Inhibitors Found Not to Be Linked to Poor Pregnancy Outcomes - HCPLive

Added to Collection on: 2023-11-11 21:08:26

Tags for this article:

Immunosuppressants
Monoclonal antibodies
Rheumatology
Autoimmune diseases
Connective tissue diseases
TNF inhibitor
Rheumatoid arthritis
Methotrexate
Pregnancy
Infliximab
Tumor necrosis factor
Childbirth

Click the tags to see associated articles and topics

View Article Details
ODESSA-UC Study Compares Dose Escalation in Vedolizumab, AntiTNF-α for Ulcerative Colitis

Added to Collection on: 2023-12-02 14:04:01

Tags for this article:

Monoclonal antibodies
Immunosuppressants
Autoimmune diseases
TNF inhibitors
Abdominal pain
Vedolizumab
Infliximab
Ulcerative colitis
Adalimumab
Biopharmaceutical
Crohn's disease
Tumor necrosis factor

Click the tags to see associated articles and topics

View Article Details
Clinical Challenges: Finding New Targets in Crohn's Disease Beyond Anti-TNF

Added to Collection on: 2023-12-15 16:15:42

Tags for this article:

Autoimmune diseases
Monoclonal antibodies
Immunosuppressants
Biotechnology
Abdominal pain
Crohn's disease
Ulcerative colitis
Inflammatory bowel disease
TNF inhibitor
Vedolizumab
Infliximab
Ustekinumab
Arun Swaminath

Click the tags to see associated articles and topics

View Article Details
FDA Updates for Week of March 18, 2024: A $4.25 Million Gene Therapy and Drugs for ...

Added to Collection on: 2024-03-23 20:15:27

Tags for this article:

Biotechnology
Immunology
Antineoplastic drugs
Monoclonal antibodies
Cancer treatments
Infliximab
Biopharmaceutical
Gene therapy
Lymphoma
Interleukin 2
Denileukin diftitox
Metachromatic leukodystrophy

Click the tags to see associated articles and topics

View Article Details
Meta-Analysis Confirms Similar Safety, Efficacy Between Adalimumab Biosimilars, Humira

Added to Collection on: 2024-04-06 19:50:57

Tags for this article:

Monoclonal antibodies
Immunosuppressants
TNF inhibitors
Orphan drugs
Adalimumab
Biosimilar
Psoriasis
Infliximab
Biopharmaceutical

Click the tags to see associated articles and topics

View Article Details
Inflammatory Bowel Disease Market to Register Incremental Growth During the Forecast ...

Added to Collection on: 2024-04-12 15:11:43

Tags for this article:

Autoimmune diseases
Inflammatory bowel disease
Gastrointestinal tract disorders
Abdominal pain
Infliximab

Click the tags to see associated articles and topics

View Article Details
Celltrion receives European Commission approval of Omlyclo® (CT-P39), the first and only ...

Added to Collection on: 2024-05-24 15:59:07

Tags for this article:

Monoclonal antibodies
Specialty drugs
Orphan drugs
Immunosuppressants
TNF inhibitors
Omalizumab
Celltrion
Biosimilar
Immunoglobulin E
Infliximab
Adalimumab
Biopharmaceutical
Incheon
anti-IgE antibody
South Korea

Click the tags to see associated articles and topics

View Article Details
Survey of Clinicians: Lower Cost of Biosimilars is the Main Driver of Treatment Choice in IBD

Added to Collection on: 2024-09-07 11:06:02

Tags for this article:

Monoclonal antibodies
Immunosuppressants
Autoimmune diseases
TNF inhibitors
Disease-modifying antirheumatic drugs
Biosimilar
Infliximab
Biopharmaceutical
Adalimumab
Crohn's disease
Ulcerative colitis
Inflammatory bowel disease

Click the tags to see associated articles and topics

View Article Details
Biosimilars Month in Review: October 2024 - HCPLive

Added to Collection on: 2024-11-02 18:03:59

Tags for this article:

Immunosuppressants
Monoclonal antibodies
Disease-modifying antirheumatic drugs
TNF inhibitors
Janssen Biotech
Biosimilar
Adalimumab
Infliximab
Ustekinumab
Etanercept
Ulcerative colitis
Crohn's disease

Click the tags to see associated articles and topics

View Article Details